Invesco Biotechnology & Genome ETF
PBE
#2018
ETF rang
€0.22 Md
Capitalisation boursière
🇺🇸 US
Marché
70,49 €
Prix de l'action
1.82%
Changement (1 jour)
4.84%
Changement (1 an)

Invesco Biotechnology & Genome ETF - Composition

Composition de l'ETF au 4 Février, 2026

Nombre de participations : 32

Liste complète de la composition

Poids %NomSymboleActions détenues
5.68%
Gilead Sciences IncGILD103770
5.33%
Amgen IncAMGN38885
5.18%
Illumina IncILMN103203
5.10%
Biogen IncBIIB73517
4.95%
Regeneron Pharmaceuticals IncREGN17072
4.92%
United Therapeutics CorpUTHR27241
4.70%
Incyte CorpINCY122358
3.94%
Alnylam Pharmaceuticals IncALNY29936
3.83%
Amicus Therapeutics IncFOLD716939
3.60%
Dynavax Technologies CorpDVAX619803
2.99%
MannKind CorpMNKD1382171
2.92%
Royalty Pharma PLCRPRX178379
2.91%
QIAGEN NVQGEN150201.3786
2.87%
Ionis Pharmaceuticals IncIONS90302
2.87%
Bio-Techne CorpTECH111680
2.83%
Catalyst Pharmaceuticals IncCPRX301597
2.81%
Collegium Pharmaceutical IncCOLL155580
2.80%
Halozyme Therapeutics IncHALO95817
2.76%
BioMarin Pharmaceutical IncBMRN127758
2.69%
ACADIA Pharmaceuticals IncACAD296675
2.68%
Exelixis IncEXEL167824
2.59%
Neurocrine Biosciences IncNBIX50198
2.52%
Protagonist Therapeutics IncPTGX80859
2.52%
Vericel CorpVCEL182370
2.50%
BioCryst Pharmaceuticals IncBCRX1038146
2.46%
PTC Therapeutics IncPTCT88821
2.41%
TG Therapeutics IncTGTX221373
2.32%
Repligen CorpRGEN42392
2.16%
Madrigal Pharmaceuticals IncMDGL12061
2.05%
Veracyte IncVCYT151832
0.07%
Invesco Government & Agency PortfolioAGPXX189569.5
0.03%
CASH & EQUIVALENTSUSD84861.55